Enorama Pharma Investor Relations Material
Latest events
Q2 2025
20 Aug, 2025
Q1 2025
21 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Enorama Pharma
Access all reports
Enorama Pharma AB is a pharmaceutical company headquartered in Malmö, Sweden. The company focuses on developing and manufacturing medicated chewing gum and other nicotine products. Its main products include nicotine chewing gums and pouches aimed at aiding smoking cessation. Enorama Pharma also explores other applications such as medical cannabis chewing gums and oromucosal drug delivery systems. The company operates with a commitment to providing innovative pharmaceutical solutions. Enorama Pharma is listed on the Stockholm Stock Exchange.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ERMA
Country
🇸🇪 Sweden